Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients Receiving Chemotherapy”

185 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 185 results

Not applicableUnknownNCT04937309
What this trial is testing

Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea

Who this might be right for
Breast Cancer
University Hospital, Tours 338
Not applicableStudy completedNCT00898014
What this trial is testing

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Institut Curie 216
Not applicableActive Not RecruitingNCT04541212
What this trial is testing

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

Who this might be right for
Breast CancerLymphomaLeukemia
Montreal Heart Institute 169
Post-approval studies (Phase 4)Study completedNCT01176916
What this trial is testing

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

Who this might be right for
Breast Neoplasms
Pfizer 564
Testing effectiveness (Phase 2)Study completedNCT03948477
What this trial is testing

Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy

Who this might be right for
OncologyBreast CancerChemotherapy-induced Nausea and Vomiting
University of Auckland, New Zealand 160
Not applicableEnrolling By InvitationNCT01382082
What this trial is testing

Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy

Who this might be right for
Breast CancerLymphoma
University of Rochester NCORP Research Base 1,432
Large-scale testing (Phase 3)Study completedNCT02282020
What this trial is testing

Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments

Who this might be right for
Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
AstraZeneca 266
Large-scale testing (Phase 3)Active Not RecruitingNCT05889390
What this trial is testing

Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer

Who this might be right for
HER2-negative Breast Cancer
Semmelweis University 71
Testing effectiveness (Phase 2)Study completedNCT03862144
What this trial is testing

NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Consorzio Oncotech 150
Not applicableEnrolling By InvitationNCT06376357
What this trial is testing

The Effect of Foot Massage With Roles on Cancer Patients

Who this might be right for
Breast NeoplasmsOver CancerFoot Massage
Selcuk University 54
Testing effectiveness (Phase 2)UnknownNCT01359501
What this trial is testing

Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients

Who this might be right for
LeucopeniaBreast Cancer
China Medical University Hospital 100
Not applicableStudy completedNCT03280836
What this trial is testing

Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Breast NeoplasmPhysical Activity
Milton S. Hershey Medical Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT06291064
What this trial is testing

Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
University of Chicago 85
Not applicableUnknownNCT05622617
What this trial is testing

Relationship Between Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy

Who this might be right for
Neuropathy Associated With Dysproteinaemias
Namik Kemal University 50
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Not applicableStudy completedNCT04440930
What this trial is testing

White Tea for Prevention of Chemotherapy Induced Mucositis

Who this might be right for
Oral Mucositis
Vejle Hospital 88
Not applicableStudy completedNCT00433407
What this trial is testing

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Jonsson Comprehensive Cancer Center 12
Large-scale testing (Phase 3)Study completedNCT03462251
What this trial is testing

Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line

Who this might be right for
Breast CancerHormone Receptor Positive TumorHER 2 Negative Breast Cancer
iOMEDICO AG 41
Testing effectiveness (Phase 2)Study completedNCT00679341
What this trial is testing

The Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease

Who this might be right for
Breast Cancer
Hoffmann-La Roche 137
Testing effectiveness (Phase 2)Study completedNCT03104595
What this trial is testing

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

Who this might be right for
Febrile Neutropenia
Enzychem Lifesciences Corporation 28
Load More Results